ReviewCancers2021

PD-1 and beyond to Activate T Cells in Cutaneous Squamous Cell Cancers: The Case for 4-1BB and VISTA Antibodies in Combination Therapy.

Quentin Wright et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.